James A. Schoeneck
2013 - DepoMed
In 2013, James A. Schoeneck earned a total compensation of $2.4M as President and Chief Executive Officer at DepoMed, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $425,000 |
|---|---|
| Option Awards | $674,181 |
| Salary | $590,625 |
| Stock Awards | $710,850 |
| Other | $14,074 |
| Total | $2,414,730 |
Schoeneck received $710.9K in stock awards, accounting for 29% of the total pay in 2013.
Schoeneck also received $425K in non-equity incentive plan, $674.2K in option awards, $590.6K in salary and $14.1K in other compensation.
Rankings
In 2013, James A. Schoeneck's compensation ranked 3,239th out of 12,286 executives tracked by ExecPay. In other words, Schoeneck earned more than 73.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,239 out of 12,286 | 74th |
Division Manufacturing | 1,097 out of 4,612 | 76th |
Major group Chemicals And Allied Products | 285 out of 1,462 | 81st |
Industry group Drugs | 195 out of 1,156 | 83rd |
Industry Pharmaceutical Preparations | 162 out of 890 | 82nd |
Source: SEC filing on April 14, 2016.
Schoeneck's colleagues
We found four more compensation records of executives who worked with James A. Schoeneck at DepoMed in 2013.